North America Pet Diseases Treatment Market By Disease Type (Infectious Diseases {Bacterial, Viral, Parasitic}, Non-Infectious Diseases {Chronic Diseases, Allergies and Dermatological Issues, Cancer, Cardiovascular Diseases, Endocrine Disorders}, Genetic Disorders), By Treatment Type (Medication {Prescription medications, Over-the-counter medications}, Surgical Interventions, Preventive Care, Alternative Therapies), By Pet Type (Dogs, Cats, Small Mammals, Others), By End-User (Veterinary Hospitals, Veterinary Clinics, Others), Global Market Size, Segmental analysis, Country Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Industry Outlook

The North America Pet Diseases Treatment market accounted for USD 4.50 Billion in 2024 and USD 4.85 Billion in 2025 is expected to reach USD 10.2 Billion by 2035, growing at a CAGR of around 7.7% between 2025 and 2035. The North America pet disease treatment market is gaining momentum through clinic-pharma partnerships, affordable generics, and holistic pet health solutions. The North American pet diseases treatment market is aimed at offering care and treatments for pets suffering from conditions such as those found in dogs, cats, and other pets. Greater knowledge among pet owners about their animals’ health care is driving the expansion of this market, along with treating pets as family. Many pet owners are now choosing advanced care options for chronic and sudden issues such as arthritis, cancer, problems with the skin, and infections.

New advancements in veterinary medicine, such as treatments matched to each pet and powerful AI-driven diagnostic methods, have made treatments both accurate and effective. Pet owners in remote or less developed places can now get advice from specialists and early care using telemedicine. While these treatments are improving, the high price often stops many owners from adopting them. Pet Type, an increase in pet owners, and more attention to pet health are what fuel this lucrative and active part of the veterinary business. 

Industry Experts Opinion

"Advancements in veterinary dentistry have significantly improved our ability to diagnose and treat complex oral diseases in pets, enhancing their overall health and quality of life."

• Dr. Frank J. M. Verstraete, Professor Emeritus of Veterinary Dentistry and Oral Surgery at the University of California, Davis

Report Scope:

Market Dynamics

Increasing prevalence of chronic and infectious diseases in pets

Growing numbers of chronic and infectious diseases in pets are boosting the North American pet disease treatment market. As more dogs and cats develop obesity, arthritis, and diabetes, it is now necessary for them to receive more continuing health care. About half of all dogs in U.S. animal shelters who did not show symptoms tested positive for canine infectious respiratory pathogens.

In addition, the Centers for Disease Control and Prevention (CDC) found that zoonotic diseases make up 61% of infectious diseases and 75% of those just beginning to emerge. Higher health concerns among pets mean people look for better treatments and drugs, which encourages growth in the pet disease treatment market in North America.

Advances in veterinary diagnostics and treatment technologies

Improvements in veterinary diagnostics and treatment technologies are playing a big role in fueling growth in the North American pet disease treatment market. To detect diseases precisely and quickly, veterinary medicine now uses AI, tests using cells or DNA, and wearables that track health. In California, researchers at UC Davis programmed an AI algorithm to diagnose Addison’s disease in dogs by reviewing just routine blood samples.

The National Veterinary Services Laboratories (NVSL), which is part of the USDA, is also essential for development in diagnostics by running laboratory services and assisting disease control programs. Thanks to these new technologies, the detection of diseases is improved, as is treatment, which has made the demand for veterinary services rise, driving the market forward.

Limited availability of skilled veterinary specialists in rural areas

A lack of trained veterinary professionals in rural areas greatly hinders the growth of the North American pet disease treatment market. Veterinary care in several rural and remote communities is often difficult, and the lack of qualified staff leads to late identification and treatment of pet diseases. The lack of animal healthcare where they live means most pet owners have to visit veterinarians far from home, which costs them more and takes more time. Due to the shortage, both advanced care and specialized treatments may not be accessible in rural areas.

As a result, pets in rural areas may not receive proper care for their health problems, which slows down the growth of the market. Because of this professional imbalance, new veterinary treatments and technology are slower to reach these regions. Even with telemedicine becoming more popular, veterinary care still involves actual visits by experts. By limiting new outlets, it becomes obvious that we need to focus on strengthening pet care for rural areas and help the market grow.

Increasing partnerships between veterinary clinics and pharmaceutical companies

Higher connections between veterinary clinics and pharmaceutical companies play a big role in growing the North American pet disease treatment market. Because of these collaborations, new and targeted medications for pets are developed and distributed more quickly. When pharmaceutical companies communicate with veterinary practitioners, they can notice new health problems and learn if the treatments they offer are effective. Being able to use the most up-to-date drugs and technologies directly in the clinic, veterinarians can now give more advanced care.

Working with these organizations allows us to boost reliability in drug supply at clinics. In addition, by working together, groups offer training and educational sessions for veterinarians, so they know how to handle the next advancements in pet care. The collaboration results in better care for pets and higher profit growth for the market. Since demand for specialized pet care services is increasing, such partnerships could influence improvements and better access to treatments for pet diseases.

Introduction of affordable medication alternatives and generics

Adding affordable medication options and generics is a significant opportunity for the North American pet disease treatment market. With veterinary treatments becoming more costly, pet owners are searching for efficient ways to care for their pets at a low cost. Generic drugs can do the job as well as branded ones, but for less money, so more pet owners can afford them. Because treatment is more affordable, pets receive care sooner and more often, which improves their health.

Cheaper treatments make it easier for pet owners, leading more animals in need of care to be treated. Because pet owners need more generic versions of familiar medicines, pharmaceutical companies are developing them and getting them approved. In addition, the trend helps clinics and hospitals grow their services by making new treatment options available to patients. Being able to purchase affordable medicines is helping to include more pets in pet care and fueling consistent growth in the North American pet disease treatment industry.

Segment Analysis

Based on the product type, the North America Pet Diseases Treatment Market has been classified into Infectious Diseases, Genetic Disorders. Non-infectious diseases make up the largest and strongest sector in the North American pet disease treatment market. It’s mainly because more and more senior pets are dealing with chronic diseases like arthritis, diabetes, and cancer. More and more pet owners are aware of lasting health issues, so they are choosing to use advanced diagnostics and treatments. Many visits to the vet for dogs and cats are for allergies and skin problems.

Advancements in using monoclonal antibodies and hormone therapies have aided in the increase of this part of the market. With non-infectious diseases, people often need to take medicine for a long time rather than simply use preventive treatments like vaccines for infectious illnesses. For this reason, this area of the market earns more money through ongoing patient treatment plans. Thanks to pet insurance and the wider availability of veterinary specialists, more pet owners now seek treatment for non-infectious health problems.

Based on the product type, the North America Pet Diseases Treatment Market has been classified into Medication, Surgical Interventions, Preventive Care, and Alternative Therapies. The most significant segment in the North American pet disease treatment market is medication. Both medicine that requires a prescription and those you can purchase OTC are used to handle many health problems such as infections, allergies, pains, and chronic illnesses. As pet owners learn more about pet health and find it easier to get medicines, they are using more medications.

While prescription drugs are used for arthritis, diabetes, or cancer, people reach for OTC products to treat everyday issues or prevent illness. With the help of new advances in veterinary medicine, drugs are now more suited to specific treatments and produce better outcomes. As e-commerce and online pharmacies for pets grow, more pet medications are becoming available and more are being sold. Because they are affordable and less invasive, most pets receive medications before surgery.

Regional Analysis

Veterinary healthcare relies heavily on the pet disease treatment market, thanks to the strong bond people have with their pets. As pets are seen as family, people are seeking better medical care and unique treatments for conditions such as arthritis, cancer, and skin diseases. Better treatments and more effective ways to diagnose diseases have improved the effectiveness of care for pets. Veterinarians can now reach people in rural areas more easily, thanks to telemedicine.

Although there are new developments in veterinary medicine, the high price of care is still distressing for many pet owners. More and more people are choosing pet insurance to take care of their pets and ease their finances, yet affordability still worries many. In general, the U.S. market is working on improving pets’ health with new ideas and better access to care, but is struggling with the challenges of rising prices and limited care for some.

The rise in ownership of pets and a change in mindset regarding pets as family members are driving the growth of the Canadian pet disease treatment market. Because pets are common in about two-thirds of Canadian households, veterinary clinics are now handling more frequent cases of arthritis, cancer, and dermatology issues. Adding artificial intelligence to veterinary care and inventing new tricks is boosting the effectiveness and quality of treatment for pets.

Telemedicine platforms are now helping pets get the attention of veterinarians, who may not be located nearby. Many pet owners still struggle because veterinary bills can be too high, keeping them from getting needed treatment for their pets. The Canadian government understands the value of animal health and is investing money to enhance the country’s ability to monitor and address animal diseases.  

Competitive Landscape

The North American pet diseases treatment market is shaped by several important players working on innovation, coming up with new items, and forming partnerships to preserve their position. Leaders such as Zoetis Inc., Elanco Animal Health, and IDEXX have a large variety of veterinary drugs, diagnostic tools, and therapeutic solutions. Merck Animal Health and Boehringer Ingelheim Animal Health are leading the way by funding research to come up with innovative solutions for chronic and infectious diseases.

Having a strong presence across veterinary sectors and distribution strengths, VCA Inc. and Covetrus Inc. boost the market. Other newcomers in the industry, such as Kindred Biosciences and Anivive Lifesciences, are choosing to make products like biologics and specialty drugs. The battle for business in this area continues due to ongoing innovation, while companies try to increase how well treatments work and expand access to care for animals.

North America Pet Diseases Treatment Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Recent Developments:

• In May 2025, Merck Animal Health announced that the U.S. Food and Drug Administration (FDA) approved MOMETAMAX SINGLE™, a novel, single-dose, in-clinic treatment for canine otitis externa. This product is the only FDA-approved one-dose treatment specifically labeled to address infections caused by Pseudomonas aeruginosa, as well as Staphylococcus pseudintermedius and Malassezia pachydermatis.

Report Coverage:

By Disease Type

• Infectious Diseases
  • Bacterial
  • Viral
  • Parasitic
• Non-Infectious Diseases
  • Chronic Diseases
  • Allergies and Dermatological Issues
  • Cancer
  • Cardiovascular Diseases
  • Endocrine Disorders
• Genetic Disorders

By Treatment Type

• Medication
  • Prescription medications
  • Over-the-counter medications
• Surgical Interventions
• Preventive Care
• Alternative Therapies

By Pet Type

• Dogs
• Cats
• Small Mammals
• Others

End-user

• Veterinary Hospitals
• Veterinary Clinics
• Others

By Region

North America

• U.S.
• Canada

List of Companies:

• Zoetis Inc.
• Elanco Animal Health
• IDEXX Laboratories
• Merck Animal Health
• Boehringer Ingelheim Animal Health
• VCA Inc.
• Covetrus Inc.
• Patterson Companies Inc.
• Heska Corporation
• Kindred Biosciences
• Aratana Therapeutics
• Dechra Pharmaceuticals
• BioVet Inc.
• Ceva Animal Health
• Anivive Lifesciences

Frequently Asked Questions (FAQs)

---

Related Report